Table 3.
Actual and predicted HbA1c grouped with FCG and PCG control targets.
| Group | actual <7% predicted <7% |
actual <7% predicted ≥7% |
actual ≥7% predicted <7% |
actual ≥7% predicted ≥7% |
|---|---|---|---|---|
| ADA guideline | ||||
| MEANFCG ≤ 7.2mmol/L | ||||
| MEANPCG <10.0mmol/L | 192 (79.7) | 9 (3.7) | 35 (14.5) | 5 (2.1) |
| MEANPCG ≥10.0mmol/L | 6 (6.4) | 33 (35.1) | 9 (9.6) | 46 (48.9) |
| MEANFCG >7.2mmol/L | ||||
| MEANPCG <10.0mmol/L | 7 (9.6) | 15 (20.6) | 6 (8.2) | 45 (61.6) |
| MEANPCG ≥10.0mmol/L | 0 | 49 (11.8) | 0 | 366 (88.2) |
| CDS guideline | ||||
| MEANFCG ≤ 7.0mmol/L | ||||
| MEANPCG <10.0mmol/L | 190 (84.4) | 31.2 | 31 (13.8) | 1 (0.4) |
| MEANPCG ≥10.0mmol/L | 6 (8.7) | 22 (31.2) | 9 (13.0) | 32 (46.4) |
| MEANFCG >7.0mmol/L | ||||
| MEANPCG <10.0mmol/L | 9 (10.1) | 21 (23.6) | 10 (11.2) | 49 (55.1) |
| MEANPCG ≥10.0mmol/L | 0 | 60 (13.6) | 0 | 380 (86.4) |
Data are shown as n (%).